Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456.

Clicks: 316
ID: 86803
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
hickson2020corrigendumebiomedicine Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hickson, LaTonya J;Langhi Prata, Larissa G P;Bobart, Shane A;Evans, Tamara K;Giorgadze, Nino;Hashmi, Shahrukh K;Herrmann, Sandra M;Jensen, Michael D;Jia, Qingyi;Jordan, Kyra L;Kellogg, Todd A;Khosla, Sundeep;Koerber, Daniel M;Lagnado, Anthony B;Lawson, Donna K;LeBrasseur, Nathan K;Lerman, Lilach O;McDonald, Kathleen M;McKenzie, Travis J;Passos, João F;Pignolo, Robert J;Pirtskhalava, Tamar;Saadiq, Ishran M;Schaefer, Kalli K;Textor, Stephen C;Victorelli, Stella G;Volkman, Tammie L;Xue, Ailing;Wentworth, Mark A;Wissler Gerdes, Erin O;Allison, David B;Dickinson, Stephanie L;Ejima, Keisuke;Atkinson, Elizabeth J;Lenburg, Marc;Zhu, Yi;Tchkonia, Tamara;Kirkland, James L;
Journal ebiomedicine
Year 2020
DOI
S2352-3964(19)30810-2
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.